Active Ingredient: BUDESONIDE
Proprietary Name: UCERIS
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 9MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N203634
Product Number: 001
Approval Date: Jan 14, 2013
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information